RenovoRx reported earnings of -$ 0.07 per RNXT share on Nov 5, 2026, beating analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 0.06 |
| Earnings Per Share (Surprise) | -$ 0.07 (-$ 0.01) |
| Last Year's EPS | -$ 0.08 |
| EPS YoY Change |
Out of the last 29 earnings reporting periods, RenovoRx beat analysts’ expectations 11 times and fell short of expectations 6 time(s). RenovoRx reported earnings per share of -$ 0.07 in the last report falling to reach an estimated EPS of -$ 0.06 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.06 | -$ 0.07 | -$ 0.08 | |
| Aug 12, 2026 | -$ 0.07 | -$ 0.05 | -$ 0.08 | |
| May 14, 2026 | -$ 0.08 | -$ 0.08 | -$ 0.08 | |
| Mar 30, 2026 | -$ 0.08 | -$ 0.08 | -$ 0.12 | |
| Nov 13, 2025 | -$ 0.08 | -$ 0.08 | -$ 0.10 | |
| Aug 14, 2025 | -$ 0.08 | -$ 0.08 | -$ 0.10 | |
| May 15, 2025 | -$ 0.08 | -$ 0.08 | -$ 0.07 | |
| Mar 31, 2025 | -$ 0.13 | -$ 0.12 | -$ 0.31 | |
| Nov 13, 2024 | -$ 0.12 | -$ 0.10 | -$ 0.17 | |
| Aug 13, 2024 | -$ 0.10 | -$ 0.10 | -$ 0.13 | |
| May 10, 2024 | -$ 0.14 | -$ 0.07 | -$ 0.27 | |
| Apr 2, 2024 | -$ 0.30 | -$ 0.31 | -$ 0.22 | |
| Apr 1, 2024 | -$ 0.30 | -$ 0.17 | -$ 0.36 | |
| Nov 14, 2023 | -$ 0.30 | -$ 0.13 | -$ 0.23 | |
| Nov 13, 2023 | -$ 0.30 | -$ 0.27 | -$ 0.24 | |
| Aug 16, 2023 | -$ 0.25 | -$ 0.22 | -$ 0.29 | |
| May 15, 2023 | -$ 0.25 | -$ 0.36 | -$ 0.33 | |
| Mar 2, 2023 | -$ 0.26 | -$ 0.23 | -$ 0.12 | |
| Nov 14, 2022 | -$ 0.27 | -$ 0.24 | -$ 0.27 | |
| Aug 15, 2022 | -$ 0.28 | -$ 0.29 | -$ 0.08 |
RenovoRx’s stock was trading at $ 1.31 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, RNXT’s price decreased to $ 1.13 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.07 | $ 1.31 | $ 1.13 | |
| Aug 12, 2026 | -$ 0.05 | $ 1.15 | $ 1.26 | |
| May 14, 2026 | -$ 0.08 | $ 0.8486 | $ 0.82 | |
| Mar 30, 2026 | -$ 0.08 | $ 1.13 | $ 1.01 | |
| Nov 13, 2025 | -$ 0.08 | $ 1.00 | $ 0.75 | |
| Aug 14, 2025 | -$ 0.08 | $ 1.22 | $ 0.9555 | |
| May 15, 2025 | -$ 0.08 | $ 1.05 | $ 1.18 | |
| Mar 31, 2025 | -$ 0.12 | $ 1.00 | $ 0.96 | |
| Nov 13, 2024 | -$ 0.10 | $ 1.10 | $ 1.09 | |
| Aug 13, 2024 | -$ 0.10 | $ 1.14 | $ 1.12 | |
| May 10, 2024 | -$ 0.07 | $ 1.35 | $ 1.41 | |
| Apr 2, 2024 | -$ 0.31 | $ 1.32 | $ 1.26 | |
| Apr 1, 2024 | -$ 0.17 | $ 1.34 | $ 1.24 | |
| Nov 14, 2023 | -$ 0.13 | $ 1.05 | $ 0.7436 | |
| Nov 13, 2023 | -$ 0.27 | $ 1.08 | $ 0.7524 | |
| Aug 16, 2023 | -$ 0.22 | $ 1.77 | $ 1.84 | |
| May 15, 2023 | -$ 0.36 | $ 2.01 | $ 2.21 | |
| Mar 2, 2023 | -$ 0.23 | $ 5.10 | $ 5.20 | |
| Nov 14, 2022 | -$ 0.24 | $ 1.88 | $ 1.96 | |
| Aug 15, 2022 | -$ 0.29 | $ 2.36 | $ 2.56 |
RenovoRx released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
RenovoRx missed analysts’ expectations during the last earnings period by
